Invivo Ventures Invests in EsoBiotec to Revolutionize Cancer Cell Therapy with Cutting-Edge In Vivo Engineering Platform

by Invivo Capital

Invivo Ventures announces an investment of €2 million in EsoBiotec, a pioneering biotechnology company focused on developing in vivo engineered cell therapies for cancer treatment. This investment i...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Meridia Glamping Program fund acquires a...

by Meridia Capital Partners

Meridia Capital is pleased to announce that has acquired a camping fac...

Photos Stream